Aurinia Pharmaceuticals
AUPH
#4611
Rank
โ‚ฌ1.76 B
Marketcap
13,40ย โ‚ฌ
Share price
2.02%
Change (1 day)
55.07%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): โ‚ฌ73.63 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.26 Billion. In 2024 the company made an earning of โ‚ฌ10.53 Million, an increase over its 2023 earnings that were of -โ‚ฌ64.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ73.63 M598.79%
2024 โ‚ฌ10.53 M-116.44%
2023 -โ‚ฌ64.08 Million-31.8%
2022 -โ‚ฌ93.96 Million-39.4%
2021 -โ‚ฌ0.16 Billion61.9%
2020 -โ‚ฌ95.78 Million-9.73%
2019 -โ‚ฌ0.11 Billion92.65%
2018 -โ‚ฌ55.07 Million36.39%
2017 -โ‚ฌ40.38 Million106.29%
2016 -โ‚ฌ19.58 Million-15.4%
2015 -โ‚ฌ23.14 Million65.84%
2014 -โ‚ฌ13.95 Million129.82%
2013 -โ‚ฌ6.07 Million-26.6%
2012 -โ‚ฌ8.27 Million
2010 -โ‚ฌ4.69 Million-39.22%
2009 -โ‚ฌ7.71 Million-43.78%
2008 -โ‚ฌ13.71 Million-53.19%
2007 -โ‚ฌ29.28 Million42.97%
2006 -โ‚ฌ20.48 Million-23.03%
2005 -โ‚ฌ26.61 Million36.1%
2004 -โ‚ฌ19.55 Million172.57%
2003 -โ‚ฌ7.18 Million484.61%
2002 -โ‚ฌ1.23 Million
2000 -โ‚ฌ5.83 Million453.81%
1999 -โ‚ฌ1.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.41 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ4.71 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-โ‚ฌ18.98 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA